Fund profile by ISIN IE000L4EH2K5
Invesco Markets II plc - Invesco S&P World Health Care ESG UCITS ETF Acc
Research Invesco Markets II plc - Invesco S&P World Health Care ESG UCITS ETF Acc by ISIN IE000L4EH2K5, domicile Ireland, accumulating, and 1-year price performance +23.6%.
ISINIE000L4EH2K5
TER—
DomicileIreland
Distribution policyAccumulating
Index—
Fund size11M
Holdings—
1-year price performance+23.6%
Exchange listings and tradability
| Ticker | Exchange | Currency | Country | Avg daily turnover | Avg daily shares |
|---|---|---|---|---|---|
| WHCE.SW | SW | USD | Ireland | €36K | 6,322 |
| WDHE.MI | ETFP | EUR | Ireland | €30K | 5,337 |
| WH2E.DE | XETRADefault at German brokers | EUR | Ireland | €28K | 4,901 |
| WHCE.L | LSE | USD | Ireland | €15K | 2,790 |
| WHCG.L | LSE | GBX | Ireland | €15K | 2,709 |
Avg daily turnover is the 90-day average, converted to euros so venues in different currencies can be compared; avg daily shares is the same window in units. The most traded listing is shown first. This fund trades on a German exchange. As of 2026-08-28.
Largest holdings
The 10 largest holdings make up 63.65% of the fund. As of 2026-08-25.
| Holding | Symbol | Weight |
|---|---|---|
| Eli Lilly and Co | LLY | 16.34% |
| AbbVie Inc | ABBV | 11.47% |
| Merck & Co Inc | MRK | 6.63% |
| AstraZeneca PLC | AZN.L | 4.89% |
| Novartis AG Registered Shares | NOVN.SW | 4.87% |
| Roche Holding AG Ordinary Shares new | ROP.SW | 4.47% |
| Gilead Sciences Inc | GILD | 4.05% |
| Abbott Laboratories | ABT | 3.88% |
| Amgen Inc | AMGN | 3.77% |
| Thermo Fisher Scientific Inc | TMO | 3.29% |
Performance is the historical price return of the representative listing. Distributions are excluded and past performance is not a forecast.